DE69727240D1 - Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv - Google Patents

Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv

Info

Publication number
DE69727240D1
DE69727240D1 DE69727240T DE69727240T DE69727240D1 DE 69727240 D1 DE69727240 D1 DE 69727240D1 DE 69727240 T DE69727240 T DE 69727240T DE 69727240 T DE69727240 T DE 69727240T DE 69727240 D1 DE69727240 D1 DE 69727240D1
Authority
DE
Germany
Prior art keywords
zidovudin
hiv
treatment
combinations containing
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69727240T
Other languages
English (en)
Other versions
DE69727240T2 (de
Inventor
Clair Martha Heider St
Walter Barry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614022.3A external-priority patent/GB9614022D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69727240D1 publication Critical patent/DE69727240D1/de
Publication of DE69727240T2 publication Critical patent/DE69727240T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
DE69727240T 1996-06-25 1997-06-23 Kombinationen, enthaltend VX478, Zidovudin und 3TC zur Behandlung von HIV Expired - Fee Related DE69727240T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2054396P 1996-06-25 1996-06-25
US20543P 1996-06-25
US2102796P 1996-07-02 1996-07-02
US21027P 1996-07-02
GB9614022 1996-07-04
GBGB9614022.3A GB9614022D0 (en) 1996-07-04 1996-07-04 Antiviral therapeutic combinations
PCT/EP1997/003247 WO1997049411A1 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv

Publications (2)

Publication Number Publication Date
DE69727240D1 true DE69727240D1 (de) 2004-02-19
DE69727240T2 DE69727240T2 (de) 2004-11-25

Family

ID=27268358

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727240T Expired - Fee Related DE69727240T2 (de) 1996-06-25 1997-06-23 Kombinationen, enthaltend VX478, Zidovudin und 3TC zur Behandlung von HIV

Country Status (26)

Country Link
US (1) US6544961B1 (de)
EP (1) EP0938321B1 (de)
JP (1) JP2000515852A (de)
KR (1) KR20000022226A (de)
CN (1) CN1228026A (de)
AP (1) AP9801419A0 (de)
AT (1) ATE257708T1 (de)
AU (1) AU727983B2 (de)
BR (1) BR9709939A (de)
CA (1) CA2258956A1 (de)
CO (1) CO4900074A1 (de)
CZ (1) CZ429498A3 (de)
DE (1) DE69727240T2 (de)
EA (1) EA001517B1 (de)
ES (1) ES2213217T3 (de)
HU (1) HUP9903249A3 (de)
ID (1) ID19490A (de)
IL (1) IL127351A0 (de)
IS (1) IS4915A (de)
NO (1) NO986034L (de)
NZ (1) NZ333099A (de)
PL (1) PL330747A1 (de)
TR (1) TR199802704T2 (de)
TW (1) TW469132B (de)
WO (1) WO1997049411A1 (de)
YU (1) YU58398A (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
NZ554779A (en) * 2005-02-01 2011-02-25 Troikaa Pharmaceuticals Ltd Injectable preparations of diclofenac ((2,6-dichloranilino)phenylacetic acid) and its pharmaceutically acceptable salts
ES2279707B1 (es) * 2005-11-10 2008-06-01 Combino Pharm, S.L. Formulaciones orales que comprenden 3'-azidonucleosidos.
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
WO2009011861A1 (en) * 2007-07-16 2009-01-22 Poniard Pharmaceuticals, Inc. Oral formulations for picoplatin
US20110052580A1 (en) * 2008-02-08 2011-03-03 Poniard Pharmaceuticals, Inc. Use of picoplatin and bevacizumab to treat colorectal cancer
MX367937B (es) * 2010-01-27 2019-09-12 Viiv Healthcare Co Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapéuticos.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
IL100502A (en) 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
IL100965A (en) * 1991-02-22 1999-12-31 Univ Emory 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
SK279262B6 (sk) 1991-05-16 1998-08-05 Glaxo Group Limited Protivírusová zmes, farmaceutický prostriedok s je
GB9111902D0 (en) 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9307013D0 (en) * 1993-04-02 1993-05-26 Wellcome Found Therapeutic combinations
DK0656887T3 (da) 1992-08-25 1999-07-05 Searle & Co Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
GB9503850D0 (en) 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
US5646180A (en) * 1995-12-05 1997-07-08 Vertex Pharmaceuticals Incorporated Treatment of the CNS effects of HIV
TW536403B (en) 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy

Also Published As

Publication number Publication date
HUP9903249A3 (en) 2001-04-28
ES2213217T3 (es) 2004-08-16
CA2258956A1 (en) 1997-12-31
US6544961B1 (en) 2003-04-08
ID19490A (id) 1998-07-16
DE69727240T2 (de) 2004-11-25
AU727983B2 (en) 2001-01-04
KR20000022226A (ko) 2000-04-25
CO4900074A1 (es) 2000-03-27
ATE257708T1 (de) 2004-01-15
EA001517B1 (ru) 2001-04-23
BR9709939A (pt) 1999-08-10
NO986034D0 (no) 1998-12-22
YU58398A (en) 1999-11-22
WO1997049411A1 (en) 1997-12-31
NZ333099A (en) 2000-06-23
AP9801419A0 (en) 1998-12-31
CZ429498A3 (cs) 1999-06-16
EP0938321A1 (de) 1999-09-01
NO986034L (no) 1999-02-23
IS4915A (is) 1998-11-30
AU3262797A (en) 1998-01-14
JP2000515852A (ja) 2000-11-28
TW469132B (en) 2001-12-21
EP0938321B1 (de) 2004-01-14
HUP9903249A2 (hu) 2000-10-28
IL127351A0 (en) 1999-10-28
TR199802704T2 (xx) 1999-03-22
PL330747A1 (en) 1999-05-24
CN1228026A (zh) 1999-09-08
EA199801045A1 (ru) 1999-08-26

Similar Documents

Publication Publication Date Title
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
ATE296634T1 (de) (s,s)-reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen
DE69739303D1 (de) Vorrichtung zur thermischen behandlung von gewebe
DE69806579T2 (de) Anlage zur behandlung von nahrungsmitteln
DE69312624T2 (de) Vorrichtung zur unterscheidung von tachykardien und fibrillationen und zur entsprechenden behandlung
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69835031D1 (de) Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE69711311D1 (de) Vorrichtung zur thermischen Behandlung von Gewebe
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE3850433T2 (de) Allergiebehandlung und Zusammensetzung dafür.
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE29718503U1 (de) Gerät zur Behandlung von Tinitus und Hyperakusis
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69519602T2 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69926485D1 (de) Behandlung von durchblasgasen
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee